Evidence map›Paper›PMID 41612627›Full record

ArticleEmerging infectious diseases2026

Molecular Analysis of Emerging MT27 Macrolide-Resistant Bordetella pertussis, Kobe, Japan, 2025.

Shoko Komatsu, Noriko Nakanishi, Kousaku Matsubara, Yuui Inenaga, Masayuki Hori, Kiyo Shiotani, Rumi Morimoto, Chie Nantani, Yuki Muneta, Nobuya Kusunoki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shoko Komatsu
Noriko Nakanishi
Kousaku Matsubara
Yuui Inenaga
Masayuki Hori
Kiyo Shiotani
Rumi Morimoto
Chie Nantani
Yuki Muneta
Nobuya Kusunoki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the emergence and spread of multilocus variable-number tandem-repeat analysis type 27 (MT-27) macrolide-resistant Bordetella pertussis (MRBP) in Kobe, Japan, in 2025. Whole-genome sequencing revealed that MT27-MRBP did not originate from the widely circulating MT27 macrolide-sensitive B. pertussis in Japan but was closely related to MRBP in China.

Indexed as

Anti-Bacterial AgentsBordetella pertussisDrug Resistance, BacterialMacrolidesWhooping CoughHumansJapanMicrobial Sensitivity TestsMinisatellite RepeatsMultilocus Sequence TypingPhylogenyWhole Genome SequencingAnti-Bacterial AgentsMacrolidesantimicrobial resistancebacteriaBordetella pertussisJapanmacrolide-resistant Bordetella pertussisMRBPMT27prn150

Identifiers

PMID41612627
PMCPMC12872074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.